Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted EBIT Margin of 34.04% for Q2 2026, up 41.83 percentage points from -7.79% a year earlier.
Powered by 
Analysis
Eton Pharmaceuticals (ETON) EBIT Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT Margin at Eton Pharmaceuticals was 12.39%, up 13.78 percentage points year-over-year; for FY2025, it came in at -1.06%, up 5.60 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of +69514.33 percentage points (FY2020 to FY2025).
- In prior years, Eton Pharmaceuticals' EBIT Margin was -6.66% in FY2024 (-2.89 pp), -3.77% in FY2023 (+35.10 pp), -38.87% in FY2022 (-32.02 pp) and -6.85% in FY2021 (+69508.54 pp).
- The Q2 2026 figure stands as the highest quarterly EBIT Margin since Q1 2021.
- On a year-over-year basis, EBIT Margin increased in six of the last seven quarters, with an average year-over-year change of +16.32 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q3 2021, with a gain of 3141.20 percentage points; the weakest was Q1 2022, with a drop of 278.86 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.56 Bn | 25.41 Mn | 34.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.04% |
| Dec 31, 2025 | 11.58% |
| Sep 30, 2025 | -6.07% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -2.72% |
| Dec 31, 2024 | 5.40% |
| Sep 30, 2024 | 4.93% |
| Jun 30, 2024 | -32.35% |
| Mar 31, 2024 | -10.04% |
| Dec 31, 2023 | -27.25% |
| Sep 30, 2023 | -7.80% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | -47.78% |
| Dec 31, 2022 | 12.50% |
| Sep 30, 2022 | -89.93% |
| Jun 30, 2022 | -18.21% |
| Mar 31, 2022 | -233.78% |
| Dec 31, 2021 | 21.57% |
| Sep 30, 2021 | -754.45% |
| Jun 30, 2021 | -75.81% |
API Access
Eton Pharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ETON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ETON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ETON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();